SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending following a record fiscal fourth quarter characterized by significant revenue growth, a massive backlog, and robust forward guidance that signals strong demand for its electrical infrastructure equipment. Traders are responding positively to the company's manufacturing expansion and its ability to secure major contracts with hyperscale data centers, despite some prior debate regarding stock offerings.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders speculate on the timing of highly anticipated Phase 2 maintenance trial results for VK2735, with many investors anticipating significant upside or a potential acquisition if data proves superior to current obesity treatments. While some community members criticize the CEO's communication style and lack of updates at recent conferences, sentiment remains largely bullish with a focus on the underlying clinical data expected later this quarter.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Discussion is fragmented with no single finance-related catalyst dominating; community members are primarily focused on polarizing political commentary and unverified claims regarding the administration's performance, the impact of foreign policy, and various corruption allegations.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing significant community debate as traders weigh the potential for future defense contracts against frustration over delayed sales and persistent share dilution. While some investors remain optimistic about the company's role in the evolving drone warfare landscape, others express skepticism regarding executive leadership and the timing of meaningful revenue generation.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the reporting of positive final Phase 3 data for its kidney disease treatment, Trutakna, which showed significant reductions in disease progression and stabilized kidney function. While sentiment is largely bullish due to the potential for full FDA approval and best-in-class performance, some traders express frustration regarding recent price volatility and negative macro pressure on the biotech sector.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as traders express significant frustration over a prolonged downtrend, with many pointing to macroeconomic pressures like high interest rates, energy costs, and inflation as major headwinds for the building products sector. While some investors view current price levels as a long-term value opportunity based on the company's acquisition strategy, others are increasingly vocal about their dissatisfaction with leadership and continued share dilution.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending following a significant share price decline, with the community debating whether the drop presents a buying opportunity or a warning sign regarding the company's valuation. While some traders are concerned about slowing consumer spending and premium P/E multiples, others maintain a bullish outlook based on the company's strong unit growth, debt-free expansion, and resilience relative to industry peers.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's shares dropped significantly after the company reported a surprise second-quarter loss and missed revenue expectations. While the community remains divided, many traders highlight skepticism over the company's turnaround efforts and debt levels, even as some retail sentiment remains optimistic regarding management's long-term strategy.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is trending as traders express intense frustration over the stock's failure to rally despite recent declines in oil prices. The community widely attributes the ongoing price weakness to market manipulation and heavy short interest, while expressing significant dissatisfaction with management's perceived lack of transparency and effectiveness in navigating the current environment.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following the release of positive Phase 3 SHASTA-3 and SHASTA-4 topline data for plozasiran in patients with severe hypertriglyceridemia, which demonstrated significant reductions in triglycerides and acute pancreatitis events. While the positive clinical readouts prompted analyst upgrades and price target increases, the stock has experienced significant volatility and downward pressure that some traders attribute to algorithmic market-making and options hedging activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BNY Mellon ETF Trust - BNY Mellon High Yield ETF

Neutral Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Feed

News

Sentiment

Fundamentals

Info

BKHY News